Fieldpoint Private Securities’s Bristol-Myers Squibb BMY Stock Holding History

Fieldpoint Private Securities’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$341K	Sell	4,428 -2,013	-31%	-$153K	0.1%	187
2022 Q1	$470K	Buy	6,441 +188	+3%	+$12.6K	0.1%	214
2021 Q4	$390K	Sell	6,253 -1,315	-17%	-$77.1K	0.08%	250
2021 Q3	$448K	Sell	7,568 -131	-2%	-$8.63K	0.1%	214
2021 Q2	$519K	Buy	7,699 +1,544	+25%	+$101K	0.11%	196
2021 Q1	$389K	Sell	6,155 -1,376	-18%	-$85.6K	0.09%	222
2020 Q4	$467K	Buy	7,531 +2,475	+49%	+$152K	0.11%	193
2020 Q3	$305K	Buy	5,056 +557	+12%	+$33.5K	0.09%	230
2020 Q2	$265K	Buy	4,499 +688	+18%	+$41.2K	0.09%	205
2020 Q1	$212K	Sell	3,811 -114	-3%	-$6.97K	0.08%	223
2019 Q4	$252K	Sell	3,925 -97	-2%	-$5.55K	0.07%	241
2019 Q3	$204K	Sell	4,022 -167	-4%	-$7.85K	0.07%	208
2019 Q2	$190K	Sell	4,189 -9,771	-70%	-$455K	0.06%	237
2019 Q1	$666K	Buy	13,960 +339	+2%	+$16.9K	0.28%	113
2018 Q4	$708K	Sell	13,621 -899	-6%	-$48.3K	0.31%	102
2018 Q3	$901K	Buy	14,520 +901	+7%	+$53.5K	0.34%	87
2018 Q2	$754K	Sell	13,619 -1,416	-9%	-$76.5K	0.29%	99
2018 Q1	$951K	Buy	15,035 +431	+3%	+$27.7K	0.43%	67
2017 Q4	$895K	Sell	14,604 -498	-3%	-$31.1K	0.47%	56
2017 Q3	$963K	Buy	+15,102	New	+$882K	0.42%	68
2017 Q2	–	Sell	-14,602	Closed	-$794K	–	164
2017 Q1	$794K	Buy	+14,602	New	+$801K	0.62%	46

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fieldpoint Private Securities's BMY Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Bristol-Myers Squibb (BMY) stake by 31% in Q2 2022, selling an estimated $153K and leaving 4,428 shares worth $341K. The position accounts for 0.1% of the portfolio, ranked #187.

Fieldpoint Private Securities first reported a position in BMY in Q1 2017 and has held it in 21 quarters since. The position peaked at $963K in Q3 2017. 2,538 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

Fieldpoint Private Securities held 4,428 shares of Bristol-Myers Squibb worth $341K as of Q2 2022.
Fieldpoint Private Securities sold 2,013 Bristol-Myers Squibb shares in Q2 2022, an estimated $153K.
Bristol-Myers Squibb made up 0.1% of Fieldpoint Private Securities's portfolio in Q2 2022, its #187 holding.
Fieldpoint Private Securities first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 21 quarters since.
Fieldpoint Private Securities's Bristol-Myers Squibb position peaked at $963K in Q3 2017.
2,538 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.